Markets:

Overview

News

Currencies

International

Treasuries

Avantor, Inc. Common Stock (NY:AVTR)

9.140 -0.500 (-5.19%)

Official Closing Price Updated: 7:00 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Avantor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

AVTR Q4 Deep Dive: Strategic Overhaul and Market Transition Shape 2026 Outlook

February 12, 2026

Life sciences company Avantor (NYSE:AVTR) announced better-than-expected revenue in Q4 CY2025, but sales fell by 1.4% year on year to $1.66 billion. Its non-GAAP profit of $0.22 per share was in line...

Via StockStory

Avantor (AVTR) Q4 2025 Earnings Call Transcript ↗

February 11, 2026

Avantor (AVTR) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Avantor Inc (NYSE:AVTR) Stock Plunges 12% Pre-Market After Q4 Earnings Miss Estimates ↗

February 11, 2026

Via Chartmill

Topics Earnings

Avantor (NYSE:AVTR) Surprises With Q4 CY2025 Sales But Stock Drops

February 11, 2026

Life sciences company Avantor (NYSE:AVTR) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $1.66 billion. Its non-GAAP profit of $0.22 per...

Via StockStory

Avantor (AVTR) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 09, 2026

Life sciences company Avantor (NYSE:AVTR) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know.

Via StockStory

Topics Economy World Trade

3 Small-Cap Stocks We Find Risky

January 22, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

3 Stocks Under $50 We Find Risky

January 15, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Avantor Stock Down 46% This Past Year, but One Fund's $23 Million Bet Signals Turnaround Potential ↗

January 02, 2026

A bruised balance sheet, a massive impairment, and a stock down substantially, but one manager has made Avantor its biggest bet.

Via The Motley Fool

Topics Economy Regulatory Compliance

3 Reasons to Avoid AVTR and 1 Stock to Buy Instead

January 01, 2026

Over the past six months, Avantor’s shares (currently trading at $11.46) have posted a disappointing 17.5% loss, well below the S&P 500’s 9.9% gain. This was partly driven by its softer quarterly...

Via StockStory

Topics Stocks

1 Healthcare Stock to Target This Week and 2 We Question

December 31, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare...

Via StockStory

Topics Stocks

Reflecting On Research Tools & Consumables Stocks’ Q3 Earnings: Avantor (NYSE:AVTR)

December 18, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Avantor (NYSE:AVTR) and its peers.

Via StockStory

Topics Economy

Why Avantor (AVTR) Stock Is Trading Up Today

December 10, 2025

Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.2% in the afternoon session after a company director, Sanjeev K Mehra, disclosed the purchase of 350,000 shares for a total of $3.8 million....

Via StockStory

Topics Artificial Intelligence Economy

Why One Hedge Fund Just Put $246 Million Into This Life Sciences Supplier ↗

December 07, 2025

One fund has turned nearly a third of its portfolio into a bet that this beaten-down science supplier is due for a rebound.

Via The Motley Fool

Topics Economy Regulatory Compliance Supply Chain

Why One Fund Dumped Its Entire $15 Million Stake as This Defense Stock Posted $47 Billion in Backlog ↗

December 07, 2025

Why would a fund step away from a stock that’s quietly building one of the strongest backlogs in federal contracting?

Via The Motley Fool

Topics Regulatory Compliance

Why One Fund Just Bet $64 Million on a Healthcare Stock Down 63% This Past Year ↗

December 07, 2025

This hedge fund just made a bold bet on a behavioral-health giant in the middle of a reset—here’s what they may be seeing.

Via The Motley Fool

1 Safe-and-Steady Stock for Long-Term Investors and 2 We Ignore

December 01, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

Is Avantor Stock a Buy After the CEO Scooped Up Nearly $1 Million in Shares? ↗

November 22, 2025

The CEO's purchase demonstrates his confidence in Avantor stock's upside potential.

Via The Motley Fool

Topics Regulatory Compliance

Envista, Alignment Healthcare, LifeStance Health Group, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Earnings Economy

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

November 19, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Stock Market Today: Dow Jones, S&P 500 Futures Tumble—Home Depot, Axalta Coating Systems, Molina Healthcare In Focus ↗

November 18, 2025

U.S. stock futures declined on Tuesday after Monday’s sell-off. Futures of major benchmark indices were lower.

Via Benzinga

Topics Stocks

Readystate Asset Management Takes a Giant Step Back From Lab Materials Stock ↗

November 10, 2025

Readystate Asset Management Takes a Giant Step Back From Lab Materials Stock

Via The Motley Fool

Topics Economy Regulatory Compliance

Wilson Asset Eliminates Stake In 805K AVTR Shares Valued At $10.8 Million ↗

November 06, 2025

Wilson Asset Eliminates Stake In 805K AVTR Shares Valued At $10.8 Million

Via The Motley Fool

Topics Supply Chain

3 Cash-Producing Stocks That Fall Short

November 05, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

The 5 Most Interesting Analyst Questions From Avantor’s Q3 Earnings Call

November 05, 2025

Avantor’s third quarter results were met with a significant negative market reaction, reflecting investor concerns surrounding both the scale and persistence of operational headwinds. Management...

Via StockStory

Topics Earnings Economy

Is Avantor Stock a Buy After the Incoming Chairman of the Board Purchased Shares Worth Over $1 Million? ↗

November 04, 2025

Is Avantor Stock a Buy After the Incoming Chairman of the Board Purchased Shares Worth Over $1 Million?

Via The Motley Fool

Topics Economy Regulatory Compliance

Greenhaven Backs Avantor to Capture the Next Cycle in Life Sciences ↗

November 04, 2025

Greenhaven Backs Avantor to Capture the Next Cycle in Life Sciences

Via The Motley Fool

Avantor (AVTR) Stock Trades Up, Here Is Why

October 31, 2025

Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.8% in the afternoon session after a director purchased a significant amount of company stock, signaling strong insider confidence.

Via StockStory

1 Healthcare Stock with Impressive Fundamentals and 2 We Ignore

October 31, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Stocks

AVTR Q3 Deep Dive: Strategic Overhaul Launched Amid Margin and Execution Challenges

October 30, 2025

Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was...

Via StockStory

Topics Economy

Stocks Slide As Powell Cools Rate-Cut Hopes: These 15 Stocks Are Feeling The Pinch ↗

October 29, 2025

Stocks fell as Fed Chair Powell warned a December rate cut is uncertain, citing data gaps and policy division.

Via Benzinga

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Avantor, Inc. Common Stock (NY:AVTR)

Headline News about Avantor, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today